BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31738961)

  • 1. Treatments and associated outcomes of acral lentiginous melanoma: A review.
    Lobl MB; Santos C; Clarey D; Higgins S; Silva-Lopez E; Sutton A; Wysong A
    J Am Acad Dermatol; 2020 Jul; 83(1):230-234. PubMed ID: 31738961
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
    Nadiminti H; Scope A; Marghoob AA; Busam K; Nehal KS
    Dermatol Surg; 2010 Feb; 36(2):177-84. PubMed ID: 20039914
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
    Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
    J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentigo maligna : prognosis and treatment options.
    Stevenson O; Ahmed I
    Am J Clin Dermatol; 2005; 6(3):151-64. PubMed ID: 15943492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
    Diaz A; Puig-Butillé JA; Muñoz C; Costa D; Díez A; Garcia-Herrera A; Carrera C; Badenas C; Solé F; Malvehy J; Puig S; Alos L
    J Am Acad Dermatol; 2014 Oct; 71(4):839-41. PubMed ID: 25219713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dubreuilh melanoma(lentigo maligna melanoma)].
    Ollivaud L; Basset-Seguin N; Archimbaud A
    Ann Dermatol Venereol; 2001 Feb; 128(2):172-6. PubMed ID: 11275603
    [No Abstract]   [Full Text] [Related]  

  • 7. Acral lentiginous melanoma of the toe treated using Mohs surgery with sparing of the digit and subsequent reconstruction using split-thickness skin graft.
    Loosemore MP; Morales-Burgos A; Goldberg LH
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):136-8. PubMed ID: 22931051
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicopathological characteristics of 270 patients with lentigo maligna and lentigo maligna melanoma: data from a German skin cancer centre.
    Gambichler T; Kempka J; Kampilafkos P; Bechara FG; Altmeyer P; Stücker M
    Br J Dermatol; 2014 Dec; 171(6):1605-7. PubMed ID: 24958545
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of management and outcome in 65 patients with lentigo maligna.
    Al-Niaimi F; Jury CS; McLaughlin S; Herd RM
    Br J Dermatol; 2009 Jan; 160(1):211-3. PubMed ID: 19014402
    [No Abstract]   [Full Text] [Related]  

  • 10. Lentigo maligna: diagnosis and treatment.
    Bosbous MW; Dzwierzynski WW; Neuburg M
    Clin Plast Surg; 2010 Jan; 37(1):35-46. PubMed ID: 19914456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
    Bradford PT; Goldstein AM; McMaster ML; Tucker MA
    Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentigo maligna: diagnosis and treatment.
    De Luca EV; Perino F; Di Stefani A; Coco V; Fossati B; Peris K
    G Ital Dermatol Venereol; 2020 Apr; 155(2):179-189. PubMed ID: 29683288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists.
    Charles CA; Yee VS; Dusza SW; Marghoob AA; Oliveria SA; Kopf A; Rigel D; Halpern AC
    Arch Dermatol; 2005 Jun; 141(6):723-9. PubMed ID: 15967918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife Radiosurgery and Immunotherapy as Primary Treatment for a Malignant Tumor of the Cranial Base Beginning as Lentigo Maligna: A Case Report.
    Mureb M; Benjamin C; Sen C; Spino M; Krasnozhen-Ratush O; Zagzag D; Pavlick AC; Kondziolka D
    Pract Radiat Oncol; 2019 Nov; 9(6):e608-e612. PubMed ID: 31129314
    [No Abstract]   [Full Text] [Related]  

  • 15. [Local recurrence and survival in acral lentiginous melanoma comparing 3D histology and conventional histology].
    Schulz C; Häfner HM; Breuninger H; Leiter U
    J Dtsch Dermatol Ges; 2014 Oct; 12(10):881-90. PubMed ID: 25262892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma in situ of lentigo maligna type in a young woman.
    Helm MF; Bax MJ; Augenblick DJ; Chung CG
    Int J Dermatol; 2017 Sep; 56(9):961-962. PubMed ID: 28436025
    [No Abstract]   [Full Text] [Related]  

  • 17. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
    Tas F; Erturk K
    Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lentigo maligna.
    Gaspar ZS; Dawber RP
    Australas J Dermatol; 1997 Feb; 38(1):1-6; quiz 7-8. PubMed ID: 9046644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentigo maligna.
    Smalberger GJ; Siegel DM; Khachemoune A
    Dermatol Ther; 2008; 21(6):439-46. PubMed ID: 19076621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Acral-lentiginous melanoma: Report of 15 cases.
    Manganoni AM; Facchetti F; Gavazzoni F; Farisoglio C; Manca G; Sereni E; Marocolo D; Calzavara-Pinton PG
    Dermatol Online J; 2011 Jan; 17(1):15. PubMed ID: 21272506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.